Abstract
An aspect of the invention relates to methods and implants comprising acoustic-sensitive material and at least one additional component within said acoustic-sensitive material. In some embodiments, the at least one additional component is one or more of at least one releasable drug within said acoustic-sensitive material and/or a plurality of cells within said acoustic-sensitive material. In some embodiments, the implant comprises a dedicated form, which is provided inside the body of the patient.
Original language | American English |
---|---|
Patent number | US2022288278 |
IPC | B33Y 80/ 00 A I |
Priority date | 3/03/22 |
State | Published - 15 Sep 2022 |